Diagnostic Value of Single Versus Dual Chamber Electrograms Recorded from an Implantable Defibrillator

Similar documents
Interactive Simulator for Evaluating the Detection Algorithms of Implantable Defibrillators

Critical Analysis of Dual-Chamber Implantable Cardioverter-Defibrillator Arrhythmia Detection

Clinical Results with the Dual-Chamber Cardioverter Defibrillator Phylax AV - Efficacy of the SMART I Discrimination Algorithm

ICD: Basics, Programming and Trouble-shooting

EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs

Introduction. * Corresponding author. Tel: þ address:

Tachyarrhythmia Suspicion and Detection

(SC-ICDs) in secondary sudden cardiac death (SCD) prevention.

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Journal of the American College of Cardiology Vol. 33, No. 7, by the American College of Cardiology ISSN /99/$20.

Introduction. CLINICAL RESEARCH Clinical Trial Design. Mohammad Saeed 1 *, Mehdi Razavi 1, Curtis G. Neason 2, and Simona Petrutiu 2. Aims.

PARAD/PARAD+ : P and R Based Arrhythmia Detection

Wide QRS Tachycardia in a Dual Chamber Pacemaker Patient: What is the Mechanism?

Automatic Identification of Implantable Cardioverter-Defibrillator Lead Problems Using Intracardiac Electrograms

Document Version Publisher s PDF, also known as Version of Record (includes final page, issue and volume numbers)

NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS

A Prospective Study Comparing the Sensed R Wave in Bipolar and Extended Bipolar Configurations: The PropR Study

A Closer Look Product Education at a glance

A Narrow QRS Complex Tachycardia With An Apparently Concentric Retrograde Atrial Activation Sequence

A New Dual Chamber Cardioverter-Defibrillator with Left Atrial Pacing Support

Analysis During Sinus Rhythm of Critical Sites in Reentry Circuits of Postinfarction Ventricular Tachycardia

Clinical Cardiac Electrophysiology

Supplemental Material

Repetitive narrow QRS tachycardia in a 61-year-old female patient with recent palpitations

Dual-Chamber Implantable Cardioverter-Defibrillator

Permanent Pacemaker Implantation Post Cardiac Surgery: A Cautionary Tale

Defibrillation testing should be routinely performed at the time of implantable cardioverter-defibrillator implantation Contra

Implantable cardioverter defibrillators (ICDs) reduce mortality

Characteristics of Rapid Rhythms Recorded Within Pulmonary Veins During Atrial Fibrillation

ICD THERAPIES: are they harmful or just high risk markers?

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

From the Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan

The Value of Rate Regularity and Multiplicity Measures to Detect Ventricular Tachycardia in the Presence of Atrial Fihrillation or Flutter

Utility of Atrial and Ventricular Cycle Length Variability in Determining the Mechanism of Paroxysmal Supraventricular Tachycardia

2010 Canadian Cardiovascular Society/ Canadian Heart Rhythm Society Training and Maintenance of Competency in Adult Clinical Cardiac

MEDTRONIC CARELINK NETWORK FOR PACEMAKERS. Comparison between the Medtronic CareLink Network for Pacemakers and Transtelephonic Monitoring

Mechanism of Immediate Recurrences of Atrial Fibrillation After Restoration of Sinus Rhythm

On Discovery. Pediatric Electrophysiology D CO. Electrophysiology. University of Texas Health Science Center at San Antonio, Texas

Diagnostic Value of the ICD Atrial Lead in Accurate Discrimination of Supraventricular from Ventricular Arrhythmias The ALTITUDE EGM Study

Shock Reduction Strategies Michael Geist E. Wolfson MC

Inappropriate Implantable Cardioverter-Defibrillator Shocks

Q & A: How to Safely Scan Patients with a SureScan MRI Pacemaker

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks

CLINICAL CARDIAC ELECTROPHYSIOLOGY Maintenance of Certification (MOC) Examination Blueprint

HRS Abstract from the ALTITUDE Clinical Science Program as presented at Heart Rhythm Society Conference, May 2011; San Francisco, CA USA

Preventive Pacing in Atrial Fibrillation

CURRICULUM GOALS AND OBJECTIVES CLINICAL CARDIOVASCULAR ELECTROPHYSIOLOGY TRAINING PROGRAM. University of Florida Gainesville, Florida

The New England Journal of Medicine

Time to Cardioversion of Recurrent Atrial Arrhythmias After Catheter Ablation of Atrial Fibrillation and Long-Term Clinical Outcome

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

EP WIRE on Management Preexcitation syndromes

UnitedHealthcare Medicare Advantage Cardiology Prior Authorization Program

Visualization of Critical Isthmus by Delayed Potential Mapping

ICD in a young patient with syncope

Bernard Belhassen, MD; Roman Fish, MD; Sami Viskin, MD; Aharon Glick, MD; Michael Glikson, MD; Michael Eldar, MD

480 April 2004 PACE, Vol. 27

Cardiac rhythm detailed monitoring by an implanted pacemaker: The iecg solution

Journal of the American College of Cardiology Vol. 36, No. 2, by the American College of Cardiology ISSN /00/$20.

Implantable Cardioverter-Defibril. Defibrillators. Ratko Magjarević

Basic Electrophysiology Protocols

SVT Discriminators. Definition of SVT Discrimination. Identify which patient populations might benefit from these features

PERMANENT PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS Considerations for intensivists

Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias. Markus Kowalsky Group 11

Performance of Atrial Fibrillation Detection in a New Single-Chamber ICD

Teaching Rounds in Cardiac Electrophysiology

2017 BDKA Review. Regularity Rate P waves PRI QRS Interpretation. Regularity Rate P waves PRI QRS Interpretation 1/1/2017

Tech Corner. ATP in the Fast VT zone

CATHETER ABLATION FOR TACHYCARDIAS

Julie A. Thompson, MSE, and Janice M. Jenkins, PhD

National Coverage Determination (NCD) for Cardiac Pacemakers (20.8)

Antitachycardia Pacemakers in Congenital Heart Disease

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation

Mission Statement for our Arrhythmia Care

Assessment of Defibrillation Threshold upon Implantable Cardioverter-Defibrillator implant in Relation to patient s prognosis

Several studies of the primary prevention. Original Research

Testing the Accuracy of ECG Captured by Cronovo through Comparison of ECG Recording to a Standard 12-Lead ECG Recording Device

INTERPRETING THE ECG IN PATIENTS WITH PACEMAKERS

Mechanism of Ventricular Tachycardia Termination by Pacing at Left Ventricular Sites in Patients with Coronary Artery Disease

2009 CPT Codes for Cardiac Device Monitoring

ICD Discrimination Algorithms

EVATEL Study. Remote follow-up of patients implanted with an ICD The prospective randomized EVATEL study

Ventricular tachycardia Ventricular fibrillation and ICD

Third-generation implantable cardioverter-defibrillators

Biphasic Clinical Summaries

Atrial Fibrillation Ablation: in Whom and How

First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator

Results of Catheter Ablation of Ventricular Tachycardia Using Direct Current Shocks

Implantable cardioverter defibrillator, Inappropriate shock, Lead failure

Biatrial Stimulation and the Prevention of Atrial Fibrillation

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

Atrial fibrillation: why it's important to make opportunities diagnosis in single chamber ICD patients

Antifibrotic Therapy Delays Progression from Paroxysmal to Persistent Atrial Fibrillation

Ventriculoatrial Block During a Narrow-QRS Tachycardia: What Is the Tachycardia Mechanism? IV

Predictors and Clinical Impact of Inappropriate Implantable Cardioverter-Defibrillator Shocks in Korean Patients

Newer pacemakers also can monitor your blood temperature, breathing, and other factors and adjust your heart rate to changes in your activity.

Determination of Inadvertent Atrial Capture During Para-Hisian Pacing

Journal of the American College of Cardiology Vol. 33, No. 3, by the American College of Cardiology ISSN /99/$20.

Cost Advantage of Dual-Chamber Versus Single-Chamber Cardioverter-Defibrillator Implantation

Practice Questions.

Transcription:

Journal of Interventional Cardiac Electrophysiology 9, 49 53, 2003 C 2003 Kluwer Academic Publishers. Manufactured in The Netherlands. Diagnostic Value of Single Versus Dual Chamber Electrograms Recorded from an Implantable Defibrillator Michael H. Kim, 1 David Bruckman, 2 Christian Sticherling, 3 Hakan Oral, 3 Frank Pelosi, 3 Bradley P. Knight, 3 Fred Morady, 3 and S. Adam Strickberger 3 1 Section of Cardiology, Rush-Presbyterian-St. Luke s Medical Center, Chicago, IL, USA; 2 Division of General Pediatrics and 3 Section of Clinical Cardiac Electrophysiology, University of Michigan, Ann Arbor, MI, USA Abstract. Introduction: The clinical utility of ventricular electrograms in comparison to atrial and ventricular electrograms in diagnosing the type of tachycardias recorded by an implantable defibrillator has not been addressed from the standpoint of a clinician s diagnostic accuracy and confidence in that diagnosis. Methods: Fifty-two tachycardia episodes recorded from dual chamber defibrillators were divided into two tests. The initial test contained only information from the ventricular electrogram and the second test contained information from both the atrial and ventricular electrograms. For each test, the reviewers were asked to provide the specific diagnosis, the originating chamber of origin of the tachycardia, and the confidence of their responses for each question. McNemar s test for matched pairs was used to determine accuracy and an analysis of variance to determine reviewer confidence. Results: The overall accuracy for both the specific diagnosis (61% vs. 79%; p < 0.001) and the chamber of origin (76% vs. 90%; p < 0.001) improved when both the atrial and ventricular electrograms were available for review. Reviewer confidence appeared to correlate with diagnostic accuracy. Conclusions: The data clearly show the favorable impact of dual chamber defibrillators on the diagnostic accuracy and confidence of clinicians faced with a clinical tachycardia recorded from an implantable defibrillator. Such improvements may translate into more focused and appropriate therapeutic interventions. Key Words. defibrillator, tachycardia, diagnosis defibrillator has not been addressed from the standpoint of a clinician s diagnostic accuracy and confidence. Presumably, the combination of atrial and ventricular electrogram recordings provide incremental diagnostic information, compared to only a ventricular electrogram recording. Therefore, the purpose of this study was to compare a group of clinicians diagnostic accuracy and confidence in determining the type of tachycardias recorded by an implantable defibrillator when provided with a ventricular electrogram alone or with atrial and ventricular electrograms. Methods Study Design Dual chamber electrogram recordings were obtained during clinical follow-up and then preselected with the intent of finding a variety of clinical tachycardias for analysis. A consensus diagnosis was made by two investigators (MHK & SAS) using standard techniques [2]. These reviewers used all available clinical information including electrocardiograms, rhythm strips, results of electrophysiology testing, and the patient history. Five additional electrophysiologists reviewed the 52 selected tachyarrhythmia episodes Introduction During clinical electrophysiologic testing, multiple endocardial catheters are used to record electrograms and determine a tachycardia s mechanism [1]. Implantable defibrillators provide either ventricular, or atrial and ventricular electrograms. The clinical utility of ventricular, or atrial and ventricular electrograms in diagnosing the type of tachycardias recorded by an implantable This work was supported in part by the Don Nouse Arrhythmia Research Fund. Address for correspondence: Michael H. Kim, M.D., Section of Cardiology, Rush-Presbyterian-St. Luke s Medical Center, 1653 W. Congress Parkway, Room 983 Jelke, Chicago, IL 60612, USA. E-mail: Michael Kim@rush.edu Received 22 October 2002; accepted 7 March 2003 49

50 Kim et al. which included 8 examples of sinus tachycardia, 11 of atrial fibrillation/flutter, 4 of paroxysmal supraventricular tachycardia, 23 of ventricular tachycardia, 3 of ventricular fibrillation, and 3 of double tachycardias. The 52 recorded tachycardia episodes were divided into 2 tests, each containing 52 tests of either single chamber or dual chamber electrograms. The tests were coded and randomized so that the sequence of episodes was different for each test. The initial test presented only the ventricular and/or shock electrogram and the marker channels. The atrial electrogram and atrial marker channel were not available for review in the initial test. Delivered therapies were also shown. Twelve of the 52 tachycardia episodes contained only the ventricular electrogram rather than both the shock and ventricular electrogram together. Tachycardia onset and/or termination was available in 32 of the 52 episodes. Electrogram morphology in sinus or supraventricular rhythm was not always available. After completion of the ventricular electrogram test, a waiting period of one month was used prior to the administration of the dual chamber electrogram test that contained the atrial and ventricular electrograms. For each test, the reviewers were asked to provide: (1) a specific diagnosis, (2) the originating chamber for the arrhythmia in question (atrial, ventricular, or both), and (3) the confidence of their responses for the previous 2 questions. Confidence ratings were based on a 5-point Likert scale: 1 = not certain, 2 = somewhat certain, 3 = certain, 4 = very certain, 5 = absolutely certain. Patient Characteristics Thirty-nine patients (29 men, 10 women) with a mean age of 59 ± 17 years at the time of defibrillator implant were the source of the arrhythmias used in this investigation. All recordings were obtained from Guidant dual chamber defibrillators (St. Paul, MN). These arrhythmias occurred 109 ± 155 days after the defibrillator was implanted. Statistical Analysis The McNemar s test for matched pairs was used to determine overall accuracy across all examiners and within each examiner. A p value < 0.05 was considered statistically significant. Reviewer confidence was analyzed using an analysis of variance to determine if confidence differed across examiners overall, when the ventricular electrogram only determination for the specific diagnosis and chamber of origin was correct or incorrect, and when the atrial and ventricular electrogram determination for the specific diagnosis and chamber of origin was correct or incorrect. Multiple comparisons required a significance level of p 0.01 to be considered statistically significant. Scheffe s method of adjustment was used when performing pairwise analysis. A logistic regression analysis was performed to assess the relationship between confidence and accuracy, and between tachycardia cycle length and the specific diagnosis. Results Main Findings The overall accuracy in obtaining the diagnosis with the ventricular electrogram only (single chamber) was 61%, compared to 79% with both the atrial and ventricular electrograms (dual chamber) (p < 0.001; Table 1). The proportion of correct determinations differed based on the specific diagnosis (Table 1). A significant improvement in diagnosing the chamber of origin (supraventricular, ventricular, or both (double tachycardia)) of the tachycardia was observed with the dual chamber electrograms in comparison to the single chamber electrograms. The overall accuracy increased from 76% with the ventricular electrogram to 90% when both electrograms were used (p < 0.001; Table 2). Selected cases demonstrating a benefit of the atrial lead are shown in Figures 1 and 2. Table 1. Comparison of diagnostic accuracy with single versus dual chamber electrograms Single lead Double lead Diagnosis (%) accuracy accuracy P value Overall 158/260 (61) 206/260 (79) <0.001 Sinus tachycardia 18/40 (45) 26/40 (65) 0.046 Atrial fibrillation 47/55 (85) 50/55 (91) 0.40 Paroxysmal SVT 1/20 (5) 12/20 (60) <0.001 Ventricular tachycardia 78/115 (68) 97/115 (84) <0.001 Ventricular fibrillation 14/15 (93) 14/15 (93) NS Double tachycardia 0/15 (0) 7/15 (47) <0.0001 NS: Not significant. SVT: Supraventricular tachycardia. Table 2. Comparison of diagnostic accuracy in diagnosing the tachycardia s chamber of origin with single versus dual chamber electrograms Single lead Dual lead P Diagnosis (%) accuracy accuracy value Overall 197/260 (76) 233/260 (90) <0.001 Supraventricular only 97/115 (84) 107/115 (93) 0.03 Ventricular only 100/130 (77) 119/130 (92) <0.001 Double tachycardia 0/15 (0) 7/15 (47) N/A N/A: Not applicable due to small sample size.

Utility of Dual Chamber Electrograms 51 (a) Fig. 1. (a) Sinus tachycardia/av tracing. (b) Tachycardia diagnosis?/v tracing. (b) Confidence of the Reviewer Across all reviewers, the mean confidence was significantly greater when the reviewer was, in fact, correct. For the specific diagnosis and determination of the chamber of origin with the ventricular electrogram, the odds of an accurate specific diagnosis doubled (odds ratio 2.0) and increased by 61% (odds ratio 1.6), respectively, with each unit increase in confidence along the 5-point Likert scale (p < 0.0001 for both). For the specific diagnosis with the atrial and ventricular electrograms, the odds of an accurate diagnosis were 67% greater (odds ratio = 1.67) with each unit increase in confidence along a 5-point Likert scale (p < 0.01), but the odds of an accurate diagnosis of the chamber of origin of tachycardia did not correlate with confidence levels (p = 0.3). Mean confidence in the diagnosis for both the ventricular only and atrial and ventricular electrograms are shown on Table 3. In the analysis of tachycardia cycle length for both the ventricular only and the atrial and ventricular electrograms, the odds of an accurate specific diagnosis, after adjustment for all reviewers, increased only for sinus tachycardia. Specifically, the odds increased by 1.2% with each millisecond increase Table 3. scale Reviewers confidence in their diagnosis when using single versus dual chamber electrograms based on 5-point Likert Specific diagnosis mean Chamber of origin mean confidence (standard deviation) P value confidence (standard deviation) P value Single lead (correct/incorrect) 3.4 (1.1)/2.8 (1.0) <0.001 3.3 (1.1)/2.8 (1.0) 0.0004 Dual lead (correct/incorrect) 4.2 (1.0)/3.7 (1.1) <0.01 4.2 (1.0)/3.9 (1.2) 0.3

52 Kim et al. (a) Fig. 2. (a) Both AT and VT/AV tracing. (b) Tachycardia diagnosis?/v tracing. (b) in tachycardia cycle length in the ventricular only (OR = 1.01; p = 0.015) and 3% with each millisecond increase in tachycardia cycle length for the atrial and ventricular electrograms (OR = 1.03; p = 0.015). Discussion Major Findings Among patients with an implantable defibrillator, the addition of an atrial electrogram to a ventricular electrogram improved the physician s ability to determine if a tachycardia was supraventricular or ventricular and to identify the specific type of tachycardia. In addition, the odds of an accurate specific diagnosis correlated to greater confidence in evaluation of single and dual chamber electrograms. This investigation was not an assessment of the capability of a defibrillator s dual chamber detection algorithm. Thus, no comparisons can be made between dual chamber and single chamber detection algorithms. All episodes were stored by a dual chamber device and analyses were based on this stored data. This investigation addressed the impact of such recordings on the clinicians diagnostic accuracy and confidence in the diagnosis only. In this setting, the greatest clinical advantage of dual chamber electrograms was the increased accuracy from 76% to 90%, in identifying the chamber of origin of tachycardias. The improvement in accuracy was most noticeable for sinus tachycardia, paroxysmal supraventricular tachycardia, ventricular tachycardia, and double tachycardia. The clinicians single lead accuracy was diminished due to difficult, selected test cases which included double tachycardias and tachycardias (both supraventricular and ventricular) consisting of 1:1 atrial to ventricular relationships with varying tachycardia cycle lengths. Prior Studies Prospective, randomized trials of detection algorithms in patients with dual chamber defibrillators are lacking and such trials are unlikely to occur as the technology is in constant evolution. These algorithms have been shown to both reduce [3] and have no impact [4,5] on inappropriate therapies. A direct comparison of four different dual chamber detection algorithms noted appropriate detection of atrial fibrillation, but limited detection of other supraventricular tachycardias [6].

Utility of Dual Chamber Electrograms 53 Thus, the question of the dual chamber defibrillator s effectiveness in preventing inappropriate therapies is unanswered. Despite this lack of definitive data on the performance of dual chamber detection algorithms in preventing inappropriate therapies, data from the present study suggest that when physicians have access to dual chamber electrograms, it is a very useful tool for determining the type of tachycardia that was treated by the implantable defibrillator. Limitations The major limitation of this study is that the evaluated tachycardias did not occur consecutively. Instead the recordings reflect a selected variety of clinical arrhythmias across a wide range tachycardia cycle lengths. The reviewers ability to obtain the correct diagnosis was limited by the lack of information about the patient and the absence of an arrhythmia summary detailing comments such as the tachycardia onset, stability, and cycle length. This information, however, was available on the marker channels and could be inferred indirectly. Other factors which could have limited the clinicians diagnostic accuracy included the lack of uniform availability of electrograms showing tachycardia onset and termination, no ventricular shock electrogram, and the inability to compare the electrograms in sinus or supraventricular rhythm. Clinical Implications The data contained herein clearly demonstrate the favorable impact of dual chamber defibrillators on the diagnostic accuracy and confidence in determining the diagnosis of a clinical arrhythmia. An improved diagnostic accuracy when interpreting stored electrograms from an implantable defibrillator should translate to an improved and more focused therapeutic approach. This finding suggests that among patients with an indication for an implantable defibrillator, a dual chamber implantable defibrillator should be considered for patients in sinus rhythm. Additionally, a single lead implantable defibrillator system that provides atrial and ventricular electrograms may offer all of the advantages of a dual chamber implantable defibrillator without the extra lead and incremental costs associated with a conventional dual chamber implantable defibrillator. References 1. Josephson ME. Clinical Cardiac Electrophysiology: Techniques and Interpretations, 1993. 2. Hook BG, Callans DJ, Kleiman RB, Flores BT, Marchlinski FE. Implantable cardioverter-defibrillator therapy in the absence of significant symptoms: Rhythm diagnosis and management aided by stored electrogram analysis. Circulation 1993;87:1897 1906. 3. Lavergne T, Daubert JC, Chauvin M, Dolla E, Kacet S, Leenhardt A, Mabo P, Ritter P, Sadoul N, Henry C, Nitzsche R, Ripart A, Murgatroyd F. Preliminary clinical experience with the first dual chamber pacemaker defibrillator. Pacing Clin Electrophysiol 1997;20:182 188. 4. Kuhlkamp V, Dornberger V, Mewis C, Suchalla R, Bosch RF, Seipel L. Clinical experience with the new dual chamber detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol 1999;10:905 915. 5. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S, Zrenner B, Schmitt C. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001;12:134 142. 6. Hintringer F, Schwarzacher S, Eibl G, Pachinger O. Inappropriate detection of supraventricular arrhythmias by implantable dual chamber defibrillators: A comparison of four different algorithms. Pacing Clin Electrophysiol 2001;24:835 841.